Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Evaluación de una intervención adaptativa de salud móvil con apoyo entre pares para veteranos de atención primaria con malestar psicológico (Peer mHealth)

29 de septiembre de 2026 actualizado por: VA Office of Research and Development

Evaluación de una Intervención Adaptativa de Salud Móvil con Apoyo de Pares para Veteranos de Atención Primaria con Angustia Psicológica

Many Veterans experience psychological distress including depression, post-traumatic stress disorder (PTSD), anxiety and problems with sleep and anger. Services to address these problems need to be easy for Veterans to access. VA mobile health applications (mHealth apps) that teach skills to manage psychological distress are widely available. However, Veterans rarely use these apps enough to experience health benefits. Peer specialists are VA employees who are trained to use their lived experiences in mental health recovery to help other Veterans. Peers can provide support and accountability to Veterans as they use mHealth apps. Peers working in VA primary care settings are easily accessible to Veterans who receive VA services. This study aims to improve the health of Veterans by testing the effectiveness of peer-supported mHealth in reducing psychological distress. It will also test how much peer support Veterans need to improve their health with using mHealth apps.

Descripción general del estudio

Estado

Reclutamiento

Condiciones

Intervención / Tratamiento

Descripción detallada

Background: Psychological distress in Veterans Affairs (VA) primary care patients is common and often not adequately treated. The VA has a suite of evidence-informed mobile health applications (mHealth apps) for psychological distress that are frequently downloaded, but most Veterans do not use them enough to experience health benefits. Support from helping professionals, such as peer specialists, can increase app use and health benefits. The study team found that peer-supported mHealth is feasible to deliver in VA primary care, increases app engagement and is associated with high satisfaction and improved Veteran health. However, not all individuals need the same amount of support when using mHealth. This study will test an adaptive intervention using a SMART design to match patient need with specific doses of peer support for mHealth.

Significance: The long-term goal is to improve the health of Veterans with psychological distress by developing a brief and efficient stepped-care intervention that can be feasibly implemented in VA primary care settings. This proposal is highly aligned with the priorities of the operational partners in the Offices of Mental Health and Patient Centered Care & Cultural Transformation and VA BBMH. The findings will support the VA-wide expansion of the Peers in PACT program, per recent STRONG Act legislation.

Innovation & Impact: Key innovations include the use of a SMART design to develop an adaptive intervention for a high-priority patient population and the novel application of the Supportive Accountability model in which human support is critical to enhancing adherence to mHealth interventions. The proposal will also provide much needed data on the effectiveness of peers to deliver brief, structured interventions.

Specific Aims: 1) Test the effectiveness of a) stage 1 (Peer mHealth vs. Self-Managed mHealth), b) stage 2 interventions (4 sessions of Peer mHealth vs. Peer Whole Health) among slow responders and c) the embedded stepped-care treatment sequences on psychological distress and secondary outcomes (e.g., app use, cost, mental health service use, symptoms, functioning) at 12 weeks. 2) Examine candidate tailoring variables as predictors of outcomes in a) stage 1 (i.e., motivation, coping self-efficacy) and b) stage 2 (i.e., app use and unmet social needs). Race/ethnicity and sex/gender will also be explored as moderators. 3) Assess barriers and facilitators to implementing adaptive interventions for peer mHealth in PACT by interviewing key VHA leadership, staff and Veteran stakeholders.

Methodology: Participants (N=384) with significant psychological distress who are not engaged in specialty mental health care will be randomized at Stage 1 to receive either Self-Managed mHealth or one peer phone call to support mHealth. Participant response, defined as a reliable decrease in psychological distress (5-point decrease in any DASS-21 subscale) will be measured after 4 weeks. Stage 2 randomization will assign slow responders to step-up to additional mHealth peer phone calls or an alternative peer support model (peer-delivered Whole Health). Stage 1 early responders will continue/ step-down to Self-Managed mHealth. All participants will be reassessed at 12, 16 and 24 weeks post-enrollment. Psychological distress is the primary outcome. Secondary outcomes include app use, mental health service use, cost, psychological symptoms (e.g., depression, anxiety, stress, PTSD, anger, sleep), and functioning (e.g., social functioning).

Next Steps/ Implementation: Should these results support the effectiveness of the adaptive intervention, the investigators will disseminate peer training through the Peers in PACT and Tech into Care VA networks. The investigators will also prepare a new ORD application to systemically investigate how the adaptive intervention can be implemented in VA.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

384

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Kyle Possemato, PhD
  • Número de teléfono: 53551 (315) 425-4400
  • Correo electrónico: kyle.possemato@va.gov

Ubicaciones de estudio

    • California
      • Palo Alto, California, Estados Unidos, 94304-1207
        • Aún no reclutando
        • VA Palo Alto Health Care System, Palo Alto, CA
        • Contacto:
    • Massachusetts
      • Bedford, Massachusetts, Estados Unidos, 01730-1114
        • Aún no reclutando
        • VA Bedford HealthCare System, Bedford, MA
        • Contacto:
    • Michigan
      • Ann Arbor, Michigan, Estados Unidos, 48105-2303
        • Aún no reclutando
        • VA Ann Arbor Healthcare System, Ann Arbor, MI
        • Contacto:
    • New York
      • Syracuse, New York, Estados Unidos, 13210-2716
        • Reclutamiento
        • Syracuse VA Medical Center, Syracuse, NY
        • Contacto:
          • Kyle Possemato, PhD
          • Número de teléfono: 53551 (315) 425-4400
          • Correo electrónico: kyle.possemato@va.gov
        • Investigador principal:
          • Kyle Possemato, PhD
    • Pennsylvania
      • Philadelphia, Pennsylvania, Estados Unidos, 19104-4551
        • Aún no reclutando
        • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Veteran enrolled in primary care at one of 3 VA facilities (Philadelphia, PA; Ann Arbor, MI; and Bedford, MA)
  • clinically significant psychological distress on at least one DASS-21 subscale (Depression => 10, Anxiety => 8, Stress => 13)

Exclusion Criteria:

  • symptoms that may preclude active engagement in the intervention such as gross cognitive impairment or current symptoms of mania or psychosis
  • suicide risk as measured by the P4 Suicide Assessment
  • plan to engage in psychotherapy during the intervention period
  • started or changed the dose of a psychotropic medication in the last two months
  • voice a preference to be directly referred to mental health specialty care

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación Secuencial
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Stage 1

Stage 1 randomization

Patients use mHealth apps to manage psychological distress

Patients receive one session with a peer while using mHealth apps to manage psychological distress

Experimental: Stage 2

Stage 2 randomization

Patients use mHealth apps to manage psychological distress

Patients receive 4 sessions with a peer while using mHealth apps to manage psychological distress

Patients receive 4 session with a peer focused on Whole Health

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Depression Anxiety and Stress Scale
Periodo de tiempo: baseline to 24 weeks

Depression Anxiety and Stress Scale is a widely used measure of psychological distress consisting of 21 items measured on a 4-point scale. The total score ranges from 0-63. Higher scores indicate greater severity.

baseline to 24 weeks

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Post Traumatic Stess Checklist-5
Periodo de tiempo: baseline to 24 weeks

Self report measure assessing the 21 symptoms of post-traumatic stress disorder (PTSD) on a 5 point scale. Total score ranges from 0-105. Higher scores indicate greater severity.

baseline to 24 weeks
Insomnia Severity Index
Periodo de tiempo: baseline to 25 weeks

Self report measure assessing insomnia with 7 questions on a 5 point scale. Total score range from 0-28. Higher scores indicate greater severity.

baseline to 25 weeks
Dimensions of Anger Reactions
Periodo de tiempo: baseline to 24 weeks

Self report measure assessing anger with 5 items on a 5 point scale. Total score ranges from 5-25. Higher scores indicate greater severity.

baseline to 24 weeks
Brief Inventory of Psychosocial Functioning
Periodo de tiempo: baseline to 24 weeks

Self report measure of psychosocial functioning measured with 7 items on 7 point scale. Total ranges from 0-42. Higher scores indicate more dysfunction.

baseline to 24 weeks
Satisfaction with Life Questionnaire
Periodo de tiempo: baseline to 24 weeks

Self report measure assessing life satisfaction with 5 items on an eight point scale. Total score ranges from 5-35. High scores indicate greater satisfaction.

baseline to 24 weeks
Client Satisfaction Questionnaire
Periodo de tiempo: baseline to 24 weeks

Self report measure assessing participant satisfaction with study interventions with 8 items measures on a 4 point scale. Total score ranges from 0-24. Higher scores indicate greater satisfaction.

baseline to 24 weeks

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
University of Rhode Island Change Assessment
Periodo de tiempo: baseline to 24 weeks

Self report measure assessing patient motivation to address psychological distress with 12 items on a 5 point scale. Total score ranges from 12 to 60. Higher scores indicate more motivation.

baseline to 24 weeks
Coping Self Efficacy Scale
Periodo de tiempo: baseline to 24 weeks

Self report measure to assess patient self efficacy to address psychological distress with 26 items on a 11 point scale. Total score ranges from 0-260 with higher scores indicating greater self-efficacy.

baseline to 24 weeks
Assessing Circumstances and Offering Resources for Needs
Periodo de tiempo: baseline to 24 weeks

Measure of unmet social needs that include 11 questions. The total score ranges from 0-48 with higher scores indicating more unmet needs.

baseline to 24 weeks

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Kyle Possemato, PhD, Syracuse VA Medical Center, Syracuse, NY

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

27 de septiembre de 2026

Finalización primaria (Estimado)

30 de abril de 2029

Finalización del estudio (Estimado)

30 de abril de 2030

Fechas de registro del estudio

Enviado por primera vez

27 de marzo de 2026

Primero enviado que cumplió con los criterios de control de calidad

27 de marzo de 2026

Publicado por primera vez (Actual)

2 de abril de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

2 de octubre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

29 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • HSR4-014-24W
  • 1I01RD000522-01A2 (Subvención/contrato del NIH de EE. UU.)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

producto fabricado y exportado desde los EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .